Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS ClinicalTrials.gov record update

Comparing the Effects of THERA°PEARL Eye Mask (Bausch & Lomb Inc., New York, USA) With the Use of Blephasteam® (Spectrum Thea Pharmaceuticals LTD, Macclesfield, UK).

This page presents selected fields from the linked source record. It does not add a medical interpretation.

Open original source record ↗

Record identity and dates

Source
ClinicalTrials.gov
Source record ID
NCT03318874
Title field or adapter rule
protocolSection.identificationModule.officialTitle
Ingested At
2026-04-28T10:38:23.910359+00:00
Published At
2021-11-22T00:00:00+00:00
Record Updated At
2021-11-22
Timestamp Basis
source retrieval time was not retained by the feed adapter
Date limitation
source retrieval time was not retained by the feed adapter

Fields recorded by this source

protocolSection.conditionsModule.conditions
["Dry Eye Syndromes", "Meibomian Gland Dysfunction"]
protocolSection.statusModule.lastUpdatePostDateStruct.date
"2021-11-22"
protocolSection.identificationModule.nctId
"NCT03318874"
protocolSection.identificationModule.officialTitle
"Comparing the Effects of THERA\u00b0PEARL Eye Mask (Bausch \u0026 Lomb Inc., New York, USA) With the Use of Blephasteam\u00ae (Spectrum Thea Pharmaceuticals LTD, Macclesfield, UK)."
protocolSection.statusModule.overallStatus
"COMPLETED"
protocolSection.designModule.phases
["PHASE4"]
protocolSection.statusModule.resultsFirstPostDateStruct.date
""

Study condition terms

  • Dry Eye Syndromes (protocolSection.conditionsModule.conditions)
  • Meibomian Gland Dysfunction (protocolSection.conditionsModule.conditions)

Intervention details are not present in the imported fields for this record. No drug-condition relationship is inferred from co-listing.

This index keeps the source fields it imported; it may not contain the complete original record. Verify wording and context in the linked source.